Bristol-Myers Squibb Company : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report
- ID: 2393792
- January 2013
- 34 pages
- iCD Research
ICD Research's "Bristol-Myers Squibb Company : Pharmaceuticals and Healthcare - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, company history, financial analysis, key employees, company locations and subsidiaries, employee biographies as well as competitive benchmarking data.
This report is a crucial resource for industry executives and anyone looking to access key information about "Bristol-Myers Squibb Company"
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
- Examines and identifies key information and issues about "Bristol-Myers Squibb Company" for business intelligence requirements.
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- Provides data on company financial performance and competitive benchmarking.
- The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of "Bristol-Myers Squibb Company"
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors' businesses better.
- Recognize potential partnerships and suppliers.
Bristol-Myers Squibb Company (BMS) discovers, develops, licenses, manufactures and markets biopharmaceuticals and related healthcare products. It principally offers products in the fields of cancer, infectious diseases, psychiatry disorders, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis, cardiovascular and metabolic disorders and immune disorders. The company's products are sold to wholesalers, retail pharmacies, hospitals, government entities and medical professions. It also focuses on research and development (RandD) activities to develop medicines for the treatment of serious diseases. The company operates in various regions across Asia, Europe, North America and Latin America. It has manufacturing facilities in the US, Puerto Rico and in six other foreign countries. BMS is headquartered in New York, the US. SHOW LESS READ MORE >
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset and Liabilities
2.2.3 Operational Efficiency
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.3 Turnover - Inventory and Asset
3 SWOT Analysis
3.1 SWOT Analysis - Overview
5 Key Employees
6 Key Employee Biographies
7 Locations and Subsidiaries
7.1 Head Office
7.2 Other Locations and Subsidiaries
8.2 Ratio Definitions
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries
Table 9: Locations
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Operational Efficiency
Figure 4: Solvency
Figure 5: Valuation
Figure 6: Market Capitalization
Figure 7: Efficiency
Figure 8: Turnover - Inventory and Asset
Figure 9: Liquidity